Autologous cancer vaccines
US11839648B2 · kind B2 · utility
0Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2019 |
| Grant date | Dec 12, 2023 |
| Priority date | — |
| Expiry date | Feb 26, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/60
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an autologous cancer vaccine and also to the method for producing same comprising the following steps: a) extracting the proteins contained in a serum or plasma sample obtained from a patient suffering from cancer; and b) bringing the proteins extracted in step a) into contact with particles of hydroxyapatite and/or tricalcium phosphate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.